Search results
'90 Day Fiancé' Recap: Angela Gets Proof Michael Is Scamming Her
Entertainment Tonight· 8 hours agoSunday's episode of 90 Day Fiancé: Happily Ever After? was shocking as it appears Angela discovered...
Digital finance is a money-launderer’s dream, argues an author
The Economist· 37 minutes agoCUTTING-EDGE FINANCIAL technology is fast becoming the handmaiden of organised crime, helping some of the world’s most dangerous crooks to move and hide ill-gotten gains. This situation will ...
TikTok acts as 'virtual strip club,' allowing adults to pay for kids' content, Utah lawsuit alleges
Fox News via Yahoo News· 6 days agoA Utah lawsuit is accusing TikTok of harming children through LIVE, arguing that the app's streaming...
Treasury Services Is Entering Its AI and Automation Era
PYMNTS.com· 6 days agoAfter all, the larger the scale and greater the diversity of a firm’s operations, the larger the...
Is The Stock Market In A Bubble?
Forbes· 2 days agoThe phenomenon has resulted in descriptors that remind us of the parable of the blind men and the elephant (see here). The elephant is the massive bull market rally in the ...
FX daily: The big reveal from the ECB
The Forex Market· 4 days agoFX markets are calmer following some stability in the Mexican peso.
Bungie Warns Of Known Issues Ahead Of Destiny 2: The Final Shape Release
GameSpot· 6 days agoWith not long to go now before Destiny 2 comes back online for the Final Shape launch, Bungie has...
Biden’s economic incompetence on full display at SEC
The Washington Times· 6 days agoIs it incompetence or intentional? Security and Exchange Commission Chairman Gary Gensler has become a model for this administration’s failures, placing...
India Stocks Hit High On Modi Landslide, Mexican Peso Slips On Election, AI Advancements - Apple...
Benzinga· 7 days agoPlease click here for an enlarged chart of India ETF EPI. The Arora Report has been sharing with...
Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with...
Benzinga· 5 days agoNew data from the ELATIVE® Phase III trial show 70% of patients treated with elafibranor achieved composite endpoint of slowing disease progression measured by biochemical response after 78-weeksData from the itch